Literature DB >> 22422631

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Debbie Saslow1, Diane Solomon, Herschel W Lawson, Maureen Killackey, Shalini L Kulasingam, Joanna Cain, Francisco A R Garcia, Ann T Moriarty, Alan G Waxman, David C Wilbur, Nicolas Wentzensen, Levi S Downs, Mark Spitzer, Anna-Barbara Moscicki, Eduardo L Franco, Mark H Stoler, Mark Schiffman, Philip E Castle, Evan R Myers.   

Abstract

An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical precancerous lesions and cancer is presented. The guidelines are based on a systematic evidence review, contributions from 6 working groups, and a recent symposium cosponsored by the ACS, the American Society for Colposcopy and Cervical Pathology, and the American Society for Clinical Pathology, which was attended by 25 organizations. The new screening recommendations address age-appropriate screening strategies, including the use of cytology and high-risk human papillomavirus (HPV) testing, follow-up (eg, the management of screen positives and screening intervals for screen negatives) of women after screening, the age at which to exit screening, future considerations regarding HPV testing alone as a primary screening approach, and screening strategies for women vaccinated against HPV16 and HPV18 infections.
Copyright © 2012 American Cancer Society, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22422631      PMCID: PMC3801360          DOI: 10.3322/caac.21139

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  150 in total

1.  New American Cancer Society process for creating trustworthy cancer screening guidelines.

Authors:  Otis Brawley; Tim Byers; Amy Chen; Michael Pignone; David Ransohoff; Maryjean Schenk; Robert Smith; Harold Sox; Alan G Thorson; Richard Wender
Journal:  JAMA       Date:  2011-12-14       Impact factor: 56.272

2.  Adding a test for human papillomavirus DNA to cervical-cancer screening.

Authors:  Thomas C Wright; Mark Schiffman
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

3.  Screening interval and risk of invasive squamous cell cervical cancer.

Authors:  Marie Grisham Miller; Hai-Yen Sung; George F Sawaya; Kathleen A Kearney; Walter Kinney; Robert A Hiatt
Journal:  Obstet Gynecol       Date:  2003-01       Impact factor: 7.661

4.  Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing.

Authors:  Jerome L Belinson; Hui Du; Bin Yang; Ruifang Wu; Suzanne E Belinson; Xinfeng Qu; Robert G Pretorius; Xin Yi; Philip E Castle
Journal:  Int J Cancer       Date:  2011-08-16       Impact factor: 7.396

5.  National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-08-26       Impact factor: 17.586

6.  The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions.

Authors:  Susan Hariri; Elizabeth R Unger; Suzanne E Powell; Heidi M Bauer; Nancy M Bennett; Karen C Bloch; Linda M Niccolai; Sean Schafer; Lauri E Markowitz
Journal:  Cancer Causes Control       Date:  2011-11-23       Impact factor: 2.506

7.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

8.  Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.

Authors:  Dorien C Rijkaart; Johannes Berkhof; Lawrence Rozendaal; Folkert J van Kemenade; Nicole W J Bulkmans; Daniëlle A M Heideman; Gemma G Kenter; Jack Cuzick; Peter J F Snijders; Chris J L M Meijer
Journal:  Lancet Oncol       Date:  2011-12-14       Impact factor: 41.316

9.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

10.  Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

Authors:  Mark E Sherman; Attila T Lorincz; David R Scott; Sholom Wacholder; Philip E Castle; Andrew G Glass; Iwona Mielzynska-Lohnas; Brenda B Rush; Mark Schiffman
Journal:  J Natl Cancer Inst       Date:  2003-01-01       Impact factor: 13.506

View more
  346 in total

1.  Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer.

Authors:  Nancy E Joste; Brigitte M Ronnett; William C Hunt; Amanda Pearse; Erika Langsfeld; Thomas Leete; MaryAnn Jaramillo; Mark H Stoler; Philip E Castle; Cosette M Wheeler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-02       Impact factor: 4.254

Review 2.  Health screening for older people-what are the current recommendations?

Authors:  S G Sazlina
Journal:  Malays Fam Physician       Date:  2015-04-30

3.  Design of a Novel Low Cost Point of Care Tampon (POCkeT) Colposcope for Use in Resource Limited Settings.

Authors:  Christopher T Lam; Marlee S Krieger; Jennifer E Gallagher; Betsy Asma; Lisa C Muasher; John W Schmitt; Nimmi Ramanujam
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

4.  Salud es Vida: a Cervical Cancer Screening Intervention for Rural Latina Immigrant Women.

Authors:  John S Luque; Yelena N Tarasenko; Claudia Reyes-Garcia; Moya L Alfonso; Norma Suazo; Laura Rebing; Daron G Ferris
Journal:  J Cancer Educ       Date:  2017-12       Impact factor: 2.037

Review 5.  Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement.

Authors:  Debbie Saslow; Kimberly S Andrews; Deana Manassaram-Baptiste; Lacey Loomer; Kristina E Lam; Marcie Fisher-Borne; Robert A Smith; Elizabeth T H Fontham
Journal:  CA Cancer J Clin       Date:  2016-07-19       Impact factor: 508.702

6.  Cervical Cancer Screening Intervals Preferred by U.S. Women.

Authors:  Crystale Purvis Cooper; Mona Saraiya
Journal:  Am J Prev Med       Date:  2018-07-20       Impact factor: 5.043

7.  Filling a gap in cervical cancer screening programmes.

Authors:  Nicolas Wentzensen; Mark Schiffman
Journal:  Lancet Oncol       Date:  2014-02-13       Impact factor: 41.316

8.  Associations between provider designation and female-specific cancer screening in women Veterans.

Authors:  Bevanne Bean-Mayberry; Lori Bastian; Mark Trentalange; Terrence E Murphy; Melissa Skanderson; Heather Allore; Evelyn Reyes-Harvey; Natalya C Maisel; Vera Gaetano; Steven Wright; Sally Haskell; Cynthia Brandt
Journal:  Med Care       Date:  2015-04       Impact factor: 2.983

9.  Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S.

Authors:  Philip E Castle; Cosette M Wheeler; Nicole G Campos; Stephen Sy; Emily A Burger; Jane J Kim
Journal:  Prev Med       Date:  2018-03-14       Impact factor: 4.018

10.  Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.

Authors:  Jane J Kim; Emily A Burger; Stephen Sy; Nicole G Campos
Journal:  J Natl Cancer Inst       Date:  2016-10-18       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.